loading
前日終値:
$35.53
開ける:
$35.72
24時間の取引高:
693.87K
Relative Volume:
0.45
時価総額:
$6.53B
収益:
$520.18M
当期純損益:
$-348.13M
株価収益率:
-18.52
EPS:
-1.92
ネットキャッシュフロー:
$-176.18M
1週間 パフォーマンス:
-5.17%
1か月 パフォーマンス:
-19.22%
6か月 パフォーマンス:
-10.43%
1年 パフォーマンス:
-38.03%
1日の値動き範囲:
Value
$35.49
$36.80
1週間の範囲:
Value
$35.10
$38.12
52週間の値動き範囲:
Value
$27.34
$59.62

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name
名前
Legend Biotech Corp Adr
Name
セクター
Healthcare (1157)
Name
電話
-
Name
住所
-
Name
職員
2,700
Name
Twitter
@LegendBiotech
Name
次回の収益日
2025-03-11
Name
最新のSEC提出書
Name
LEGN's Discussions on Twitter

LEGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LEGN
Legend Biotech Corp Adr
35.56 6.91B 520.18M -348.13M -176.18M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Redburn Atlantic Buy
2024-06-17 開始されました Truist Buy
2024-05-24 繰り返されました H.C. Wainwright Buy
2024-05-23 開始されました Deutsche Bank Buy
2024-04-17 アップグレード Scotiabank Sector Perform → Sector Outperform
2024-04-03 開始されました Cantor Fitzgerald Overweight
2024-03-13 開始されました Raymond James Outperform
2023-12-19 開始されました Scotiabank Sector Perform
2023-11-06 開始されました Goldman Buy
2023-05-25 開始されました William Blair Mkt Perform
2023-05-22 開始されました Daiwa Securities Buy
2023-03-29 開始されました H.C. Wainwright Buy
2023-03-24 開始されました RBC Capital Mkts Outperform
2022-12-06 開始されました UBS Buy
2022-11-02 開始されました Evercore ISI Outperform
2022-11-01 開始されました Cowen Outperform
2022-10-31 開始されました Guggenheim Neutral
2022-06-17 開始されました BMO Capital Markets Outperform
2022-03-15 開始されました Barclays Overweight
2022-01-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-21 開始されました Piper Sandler Overweight
2021-05-18 開始されました BTIG Research Buy
2020-07-01 開始されました JP Morgan Overweight
2020-07-01 開始されました Jefferies Buy
2020-06-30 開始されました Morgan Stanley Overweight
すべてを表示

Legend Biotech Corp Adr (LEGN) 最新ニュース

pulisher
Aug 19, 2025

PNC Financial Services Group Inc. Buys 3,238 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Aug 19, 2025
pulisher
Aug 19, 2025

Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Boosted by Swiss National Bank - Defense World

Aug 19, 2025
pulisher
Aug 19, 2025

US Bancorp DE Lowers Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World

Aug 19, 2025
pulisher
Aug 18, 2025

Legend Biotech names Carlos Santos as new CFO - Investing.com

Aug 18, 2025
pulisher
Aug 14, 2025

Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition By Investing.com - Investing.com South Africa

Aug 14, 2025
pulisher
Aug 13, 2025

Company News for Aug 12, 2025 - NewsBreak: Local News & Alerts

Aug 13, 2025
pulisher
Aug 13, 2025

Legend Biotech (NASDAQ:LEGN) Price Target Raised to $83.00 at Morgan Stanley - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

Legend Biotech (NASDAQ:LEGN) Receives Outperform Rating from Royal Bank Of Canada - Defense World

Aug 13, 2025
pulisher
Aug 12, 2025

Legend Biotech stock price target raised to $77 by RBC Capital - Investing.com South Africa

Aug 12, 2025
pulisher
Aug 11, 2025

Earnings call transcript: Legend Biotech Q2 2025 reveals strong revenue growth - Investing.com

Aug 11, 2025
pulisher
Aug 11, 2025

Earnings call transcript: Legend Biotech Q2 2025 reveals strong revenue growth By Investing.com - Investing.com South Africa

Aug 11, 2025
pulisher
Aug 11, 2025

Legend Biotech Q2 2025 slides: CARVYKTI sales surge 136%, adjusted profit achieved - Investing.com India

Aug 11, 2025
pulisher
Aug 11, 2025

XTX Topco Ltd Takes $307,000 Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) - Defense World

Aug 11, 2025
pulisher
Aug 07, 2025

Legend Biotech on Track for Record Losing Streak — Data Talk - Morningstar

Aug 07, 2025
pulisher
Aug 07, 2025

Cantor Fitzgerald Estimates Legend Biotech FY2025 Earnings - Defense World

Aug 07, 2025
pulisher
Jul 31, 2025

Brokerages Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $73.33 - Defense World

Jul 31, 2025
pulisher
Jul 26, 2025

Bank of New York Mellon Corp Has $4.55 Million Stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) - Defense World

Jul 26, 2025
pulisher
Jul 21, 2025

HC Wainwright Forecasts Legend Biotech Q2 Earnings - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Legend Biotech’s (LEGN) Buy Rating Reiterated at HC Wainwright - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

Q1 EPS Estimates for Legend Biotech Raised by HC Wainwright - Defense World

Jul 20, 2025
pulisher
Jul 18, 2025

Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Legend Biotech’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Legend Biotech’s SWOT analysis: stock poised for growth amid challenges - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

H.C. Wainwright reiterates Buy rating on Legend Biotech stock after strong CARVYKTI sales - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Goldman Sachs reiterates buy rating on Legend Biotech stock after strong Carvykti sales - Investing.com India

Jul 17, 2025
pulisher
Jul 11, 2025

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Shares Acquired by GAMMA Investing LLC - Defense World

Jul 11, 2025
pulisher
Jul 03, 2025

Legend Biotech stock price target lowered to $54 at UBS on growth concerns - Investing.com

Jul 03, 2025
pulisher
Jul 02, 2025

Legend Biotech stock maintains Buy rating as FDA eases CARVYKTI restrictions - Investing.com

Jul 02, 2025
pulisher
Jun 14, 2025

Legend Biotech’s SWOT analysis: carvykti’s strong performance drives stock potential By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 14, 2025

Legend Biotech’s SWOT analysis: carvykti’s strong performance drives stock potential - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - Barchart.com

Jun 13, 2025
pulisher
Jun 12, 2025

Oracle and GameStop Headline Market Cap Stock Movers on Thursday By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 10, 2025

Eli Lilly, General Electric among Tuesday’s market cap stock movers By Investing.com - Investing.com India

Jun 10, 2025
pulisher
Jun 10, 2025

Eli Lilly, General Electric among Tuesday’s market cap stock movers - Investing.com

Jun 10, 2025
pulisher
Jun 04, 2025

CARVYKTI shows lasting impact in multiple myeloma treatment By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 02, 2025

RBC Capital maintains outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

RBC Capital maintains outperform rating on Legend Biotech stock - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

BMO Capital reaffirms outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

BMO Capital reaffirms outperform rating on Legend Biotech stock - Investing.com India

Jun 02, 2025
pulisher
May 16, 2025

RBC Capital maintains Legend Biotech at outperform with $78 target By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

RBC Capital maintains Legend Biotech at outperform with $78 target - Investing.com

May 16, 2025
pulisher
May 14, 2025

AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday - Investing.com

May 14, 2025
pulisher
May 14, 2025

Legend Biotech stock holds $62 target, solid Carvykti sales growth - Investing.com India

May 14, 2025
pulisher
May 13, 2025

Legend Biotech stock holds $62 target, solid Carvykti sales growth By Investing.com - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

Truist cuts Legend Biotech stock target to $71, maintains buy rating - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Raymond James maintains Legend Biotech Outperform rating - Investing.com

May 13, 2025
pulisher
May 13, 2025

Raymond James maintains Legend Biotech Outperform rating By Investing.com - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Legend Biotech Q1 2025 sees strong CARVICTI sales boost - Investing.com India

May 13, 2025

Legend Biotech Corp Adr (LEGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
大文字化:     |  ボリューム (24 時間):